Clinical Trial Update: L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance [EARLY_Phase 1]

View source ↗

Summary

This EARLY Phase 1 clinical trial is evaluating L-Theanine to support relaxation and mood in cancer patients under surveillance and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Cancer
• Solid Tumor Cancer

Drugs mentioned

• L-theanine (L-theanine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm | EARLY_Phase 1 | Status: RECRUITING